vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and PAMT CORP (PAMT). Click either name above to swap in a different company.

PAMT CORP is the larger business by last-quarter revenue ($141.3M vs $104.5M, roughly 1.4× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs -15.1%). PAMT CORP produced more free cash flow last quarter ($-25.0M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -12.0%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

IMCR vs PAMT — Head-to-Head

Bigger by revenue
PAMT
PAMT
1.4× larger
PAMT
$141.3M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+39.4% gap
IMCR
24.3%
-15.1%
PAMT
More free cash flow
PAMT
PAMT
$10.6M more FCF
PAMT
$-25.0M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
PAMT
PAMT
Revenue
$104.5M
$141.3M
Net Profit
$-29.3M
Gross Margin
97.4%
Operating Margin
-18.8%
-27.0%
Net Margin
-20.7%
Revenue YoY
24.3%
-15.1%
Net Profit YoY
7.4%
EPS (diluted)
$-0.61
$-1.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
PAMT
PAMT
Q4 25
$104.5M
$141.3M
Q3 25
$103.7M
$150.3M
Q2 25
$98.0M
$151.1M
Q1 25
$93.9M
$155.3M
Q4 24
$84.1M
$166.5M
Q3 24
$80.2M
$182.6M
Q2 24
$75.4M
$182.9M
Q1 24
$70.5M
$182.6M
Net Profit
IMCR
IMCR
PAMT
PAMT
Q4 25
$-29.3M
Q3 25
$-177.0K
$-5.6M
Q2 25
$-10.3M
$-9.6M
Q1 25
$5.0M
$-8.1M
Q4 24
$-31.6M
Q3 24
$8.7M
$2.4M
Q2 24
$-11.6M
$-2.9M
Q1 24
$-24.4M
$281.0K
Gross Margin
IMCR
IMCR
PAMT
PAMT
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
PAMT
PAMT
Q4 25
-18.8%
-27.0%
Q3 25
-6.9%
-3.8%
Q2 25
-15.2%
-7.3%
Q1 25
-3.9%
-5.9%
Q4 24
-23.1%
-22.6%
Q3 24
-10.6%
1.3%
Q2 24
-21.2%
-0.4%
Q1 24
-37.6%
-0.4%
Net Margin
IMCR
IMCR
PAMT
PAMT
Q4 25
-20.7%
Q3 25
-0.2%
-3.7%
Q2 25
-10.5%
-6.4%
Q1 25
5.4%
-5.2%
Q4 24
-19.0%
Q3 24
10.9%
1.3%
Q2 24
-15.4%
-1.6%
Q1 24
-34.7%
0.2%
EPS (diluted)
IMCR
IMCR
PAMT
PAMT
Q4 25
$-0.61
$-1.38
Q3 25
$0.00
$-0.27
Q2 25
$-0.20
$-0.46
Q1 25
$0.10
$-0.37
Q4 24
$-0.47
$-1.44
Q3 24
$0.17
$0.11
Q2 24
$-0.23
$-0.13
Q1 24
$-0.49
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
PAMT
PAMT
Cash + ST InvestmentsLiquidity on hand
$864.2M
$83.7M
Total DebtLower is stronger
$333.9M
Stockholders' EquityBook value
$381.0M
$210.5M
Total Assets
$1.1B
$697.9M
Debt / EquityLower = less leverage
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
PAMT
PAMT
Q4 25
$864.2M
$83.7M
Q3 25
$892.4M
$115.6M
Q2 25
$882.8M
$117.3M
Q1 25
$837.0M
$102.7M
Q4 24
$820.4M
$110.7M
Q3 24
$901.3M
$92.3M
Q2 24
$859.6M
$114.0M
Q1 24
$832.8M
$125.8M
Total Debt
IMCR
IMCR
PAMT
PAMT
Q4 25
$333.9M
Q3 25
Q2 25
Q1 25
Q4 24
$325.6M
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
PAMT
PAMT
Q4 25
$381.0M
$210.5M
Q3 25
$396.6M
$239.5M
Q2 25
$388.5M
$244.9M
Q1 25
$378.5M
$269.6M
Q4 24
$360.7M
$277.5M
Q3 24
$377.8M
$308.9M
Q2 24
$359.1M
$306.7M
Q1 24
$359.5M
$314.6M
Total Assets
IMCR
IMCR
PAMT
PAMT
Q4 25
$1.1B
$697.9M
Q3 25
$1.1B
$715.2M
Q2 25
$1.1B
$707.9M
Q1 25
$1.0B
$712.6M
Q4 24
$1.0B
$741.7M
Q3 24
$1.1B
$756.7M
Q2 24
$1.0B
$733.5M
Q1 24
$994.0M
$746.4M
Debt / Equity
IMCR
IMCR
PAMT
PAMT
Q4 25
1.59×
Q3 25
Q2 25
Q1 25
Q4 24
1.17×
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
PAMT
PAMT
Operating Cash FlowLast quarter
$-32.7M
$-5.8M
Free Cash FlowOCF − Capex
$-35.5M
$-25.0M
FCF MarginFCF / Revenue
-34.0%
-17.7%
Capex IntensityCapex / Revenue
2.8%
13.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
PAMT
PAMT
Q4 25
$-32.7M
$-5.8M
Q3 25
$-4.5M
$5.9M
Q2 25
$26.0M
$12.2M
Q1 25
$435.0K
$5.0M
Q4 24
$-14.0M
$15.2M
Q3 24
$21.1M
$15.5M
Q2 24
$23.5M
$18.7M
Q1 24
$-4.6M
$9.6M
Free Cash Flow
IMCR
IMCR
PAMT
PAMT
Q4 25
$-35.5M
$-25.0M
Q3 25
$-5.2M
$2.5M
Q2 25
$25.6M
$5.9M
Q1 25
$137.0K
$-6.8M
Q4 24
$-17.5M
$-39.9M
Q3 24
$20.3M
$-33.6M
Q2 24
$23.1M
$4.1M
Q1 24
$-5.0M
$-12.2M
FCF Margin
IMCR
IMCR
PAMT
PAMT
Q4 25
-34.0%
-17.7%
Q3 25
-5.0%
1.7%
Q2 25
26.1%
3.9%
Q1 25
0.1%
-4.4%
Q4 24
-20.9%
-24.0%
Q3 24
25.3%
-18.4%
Q2 24
30.7%
2.2%
Q1 24
-7.1%
-6.7%
Capex Intensity
IMCR
IMCR
PAMT
PAMT
Q4 25
2.8%
13.6%
Q3 25
0.7%
2.3%
Q2 25
0.4%
4.2%
Q1 25
0.3%
7.6%
Q4 24
4.3%
33.1%
Q3 24
1.0%
26.9%
Q2 24
0.4%
8.0%
Q1 24
0.6%
12.0%
Cash Conversion
IMCR
IMCR
PAMT
PAMT
Q4 25
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
6.44×
Q2 24
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

Related Comparisons